May 22, 2023

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Summer Meeting Registration is Open!

The NRG Oncology 2023 Summer Meeting is now open for registration! Join us in celebrating our 10^th anniversary at our Summer Meeting in Philadelphia from Thursday, July 20, 2023 - Saturday, July 22, 2023. Sessions will be held in-person and available via streaming unless noted. Additionally, there will be virtual-only sessions on Monday and Tuesday, July 17-18, 2023.

Click here to Register Today

Join us at the Barnes

NRG Oncology will host our 10th anniversary at the Barnes Foundation on Friday, July 21 from 6-8 PM. Transportation will be provided.

AMENDMENT

GASTROINTESTINAL

NRG-RTOG 0848: Amendments 8 and 9, version dates April 11, 2023 and May 4, 2023 (posted on CTSU)

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BREAST

NRG-BR007/DEBRA: Memorandum regarding Eligibility and Endocrine Therapy Patient Compliance

NRG-BR008/HERO: This study is now open for patient enrollment and recently enrolled their first patient on the study.

3. GENITOURINARY

NRG-GU012: Amendment 1 Spanish Informed Consent Form and Translation approval posted to CTSU.

4. GYNECOLOGIC

GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY012

• NRG-GY012 is nearing its interim analysis. To provide the DMC with the best possible information, please update the patient data and address outstanding queries by Wednesday, May 31, 2023.

• NRG-GY012 is nearing its accrual target of 288 patients overall. Accrual is projected to complete by July 2023. Please plan future enrollments accordingly.

NRG-GY012 and NRG-GY023 – Reminder: BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation. 

GOG-0213: In preparation for a Final Analysis, please submit all overdue forms and address all queries for GOG-0213 no later than Monday, May 29, 2023. This trial utilizes the SEDES EDC system for form entry. If site personnel need access to SEDES for this study, please contact support@nrgoncology.org. SEDES can be accessed via the GOG Web Menu. Any questions can be directed the Data Manager, Kelly Fletcher, at fletcherk@nrgoncology.org.

NRG-GY019: Rapidly approaching the target for initial interim analysis. To provide the study team with the most accurate information, please submit all overdue data, and update any outstanding patient data queries by Wednesday, May 31, 2023. 

Printing Biospecimen Transmittal PDFs on GYN Trials

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

5. HEAD & NECK

NRG-HN008 - Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

6. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday June 7, 2023.

DRUG SAFETY AND INVESTIGATOR'S BROCHURE (IB) UPDATES

Drug Safety and Investigator’s Brochure updates have been issued for the following studies:

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website. Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

1. NRG ASCO 2023 Presentations Flyer

NRG Oncology announces their list of NRG research presentations that will occur at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago June 2-6, 2023. View and download the NRG ASCO flyer here.

2. Memorial Day Holiday Closures

The NRG Oncology Operations Offices, Statistics and Data Management Centers (SDMCs), Biospecimen Banks, Serum Bank, and McKesson's Clinical Research Services, will be closed on Monday, May 29, 2023, in observance of Memorial Day. A memorandum with more information about these closures and shipping information for the banks is posted on CTSU.

3. NRG Oncology Social Media Survey

NRG Oncology Communications is looking for your help with feedback on how you use social media and how you receive NRG Communications messaging. Please take this short, 3 minute survey so NRG Oncology can continue to improve our Communications approaches to best meet the needs of our membership.Please submit survey responses by the end of the day on June 15, 2023. Take the survey here.

4. Call for Applications for NRG Committee Leadership Position

Vice Chair, Cancer Control Committee

Application Deadline: May 26, 2023

We are seeking nominations for the position of Vice-Chair of the NRG NCORP Cancer Control committee. The successful candidate will work closely with Dr. Lisa Kachnic in continuing to lead the Cancer Control committee. Candidates for this position should have an active program of funded research and publications focused on the NRG cancer control priorities of improvement or delay in decline of neurocognitive function, reducing gender specific symptoms such as lymphedema and sexual function, and testing therapeutic delivery modifications to improve QoL and cost-effectiveness in localized cancers while maintaining efficacy. Candidates should have a track record of mentorship and a willingness to provide timely consultation to members and liaisons of NRG committees as concepts and protocols are being developed. Click here for more information. 

NRG Oncology is pleased to report the scientific article that appeared during the previous week. This publications report includes the link to the article.

JOURNAL ARTICLE

Mamounas EP, Bandos H, Rastogi P, Lembersky BC, Jeong JH, Geyer CE, Fehrenbacher L, Chia SK, Brufsky AM, Walshe JM, Soori GS, Dakhil SR, Wade JL, McCarron EC, Swain SM, Wolmark N. Ten-year Update: NRG Oncology/NSABP B-42 Randomized Trial: Extended Letrozole Therapy in Early-stage Breast Cancer. J Natl Cancer Inst. 2023 May 15:djad078. doi: 10.1093/jnci/djad078. Epub ahead of print. PMID: 37184928. Read more.

Please note the following upcoming meeting and abstract submission deadlines

UPCOMING MEETINGS

American Society of Clinical Oncology (ASCO); Jun 2-6, 2023; Chicago, IL

Society for Clinical Trials (SCT); May 21-24, 2023; Baltimore, MD

Western Association of Gynecologic Oncologists (WAGO); Jun 14-17, 2023; Monterey, CA

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Society for Radiation Oncology (ASTRO); Oct 1-4, 2023; Chicago, IL; LBA Jul 12, 2023

ESMO World Congress on Gastrointestinal Cancer; Jun 28-Jul 1, 2023; Barcelona, Spain; LBA Jun 15, 2023

European Society of Gynaecological Oncology (ESGO); Sep 28-Oct 1, 2023; Istanbul, Turkey; LBA Aug 7, 2023

European Society for Medical Oncology (ESMO) Congress; Oct 20-24, 2023; Madrid, Spain; LBA Sep 14, 2023, 9pm CEST

International Gynecologic Cancer Society (IGCS); Nov 5-7, 2023; Seoul, South Korea; Abstract & Film; TiP LBA, Aug 21, 2023

International Society for Quality-of-Life Research (ISOQOL); Oct 18-21, 2023; Calgary, AB Canada; LBA Jul 7, 2023

San Antonio Breast Cancer Symposium (SABCS); Dec 5-9, 2023; due to publications Jun 12, 2023; meeting submission deadline Jul 10, 2023; LBA Sep 30, 2023, 11:59 PM CT

Society for NeuroOncology (SNO); Nov 15-19, 2023; Vancouver, Canada; due to publications May 22, 2023; meeting submission deadline Jun 9, 2023; LBA Sep 4, 2023, 5:00 PM EDT